1887

Abstract

It was previously shown that two mutant influenza A viruses expressing C-terminally truncated forms of the NS1 protein (NS1-81 and NS1-110) were temperature sensitive . These viruses contain HA, NA and M genes derived from influenza A/WSN/33 H1N1 virus (mouse-adapted), and the remaining five genes from human influenza A/Victoria/3/75 virus. Mice intranasally infected with the NS1 mutant viruses showed undetectable levels of virus in lungs at day 3, whereas those infected with the NS1 wild-type control virus still had detectable levels of virus at this time. Nevertheless, the temperature-sensitive mutant viruses induced specific cellular and humoral immune responses similar to those induced by the wild-type virus. Mice immunized with the NS1 mutant viruses were protected against a lethal challenge with influenza A/WSN/33 virus. These results indicate that truncations in the NS1 protein resulting in temperature-sensitive phenotypes correlate with attenuation without compromising viral immunogenicity, an ideal characteristic for live attenuated viral vaccines.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80991-0
2005-10-01
2019-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/10/2817.html?itemId=/content/journal/jgv/10.1099/vir.0.80991-0&mimeType=html&fmt=ahah

References

  1. Aragón, T., de La Luna, S., Novoa, I., Carrasco, L., Ortín, J. & Nieto, A. ( 2000; ). Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol 20, 6259–6268.[CrossRef]
    [Google Scholar]
  2. Enami, M., Luytjes, W., Krystal, M. & Palese, P. ( 1990; ). Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci U S A 87, 3802–3805.[CrossRef]
    [Google Scholar]
  3. Falcón, A. M., Marión, R. M., Zürcher, T., Gómez, P., Portela, A., Nieto, A. & Ortín, J. ( 2004; ). Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol 78, 3880–3888.[CrossRef]
    [Google Scholar]
  4. Ferko, B., Stasakova, J., Sereinig, S., Romanova, J., Katinger, D., Niebler, B., Katinger, H. & Egorov, A. ( 2001; ). Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice. J Virol 75, 8899–8908.[CrossRef]
    [Google Scholar]
  5. Ferko, B., Stasakova, J., Romanova, J., Kittel, C., Sereinig, S., Katinger, H. & Egorov, A. ( 2004; ). Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol 78, 13037–13045.[CrossRef]
    [Google Scholar]
  6. Fodor, E., Devenish, L., Engelhardt, O. G., Palese, P., Brownlee, G. G. & García-Sastre, A. ( 1999; ). Rescue of influenza A virus from recombinant DNA. J Virol 73, 9679–9682.
    [Google Scholar]
  7. Fortes, P., Beloso, A. & Ortín, J. ( 1994; ). Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J 13, 704–712.
    [Google Scholar]
  8. García-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P. & Muster, T. ( 1998; ). Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324–330.[CrossRef]
    [Google Scholar]
  9. López, C. B., García-Sastre, A., Williams, B. R. G. & Moran, T. M. ( 2003; ). Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J Infect Dis 187, 1126–1136.[CrossRef]
    [Google Scholar]
  10. Lu, Y., Qian, X. Y. & Krug, R. M. ( 1994; ). The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev 8, 1817–1828.[CrossRef]
    [Google Scholar]
  11. Murata, K., García-Sastre, A., Tsuji, M. & 7 other authors ( 1996; ). Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol 173, 96–107.[CrossRef]
    [Google Scholar]
  12. Neumann, G., Watanabe, T., Ito, H. & 9 other authors ( 1999; ). Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96, 9345–9350.[CrossRef]
    [Google Scholar]
  13. Noah, D. L., Twu, K. Y. & Krug, R. M. ( 2003; ). Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307, 386–395.[CrossRef]
    [Google Scholar]
  14. Palese, P. & García-Sastre, A. ( 2002; ). Influenza vaccines: present and future. J Clin Invest 110, 9–13.[CrossRef]
    [Google Scholar]
  15. Qiu, Y. & Krug, R. M. ( 1994; ). The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol 68, 2425–2432.
    [Google Scholar]
  16. Schultz-Cherry, S., Dybdahl-Sissoko, N., Neumann, G., Kawaoka, Y. & Hinshaw, V. S. ( 2001; ). Influenza virus NS1 protein induces apoptosis in cultured cells. J Virol 75, 7875–7881.[CrossRef]
    [Google Scholar]
  17. Stasakova, J., Ferko, B., Kittel, C., Sereinig, S., Romanova, J., Katinger, H. & Egorov, A. ( 2005; ). Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol 86, 185–195.[CrossRef]
    [Google Scholar]
  18. Takasuka, N., Enami, M., Itamura, S. & Takemori, T. ( 2002; ). Intranasal inoculation of a recombinant influenza virus containing exogenous nucleotides in the NS segment induces mucosal immune response against the exogenous gene product in mice. Vaccine 20, 1579–1585.[CrossRef]
    [Google Scholar]
  19. Talon, J., Horvath, C. M., Polley, R., Basler, C. F., Muster, T., Palese, P. & García-Sastre, A. ( 2000a; ). Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74, 7989–7996.[CrossRef]
    [Google Scholar]
  20. Talon, J., Salvatore, M., O'Neill, R. E., Nakaya, Y., Zheng, H., Muster, T., García-Sastre, A. & Palese, P. ( 2000b; ). Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci U S A 97, 4309–4314.[CrossRef]
    [Google Scholar]
  21. Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J. & Fukuda, K. ( 2003; ). Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289, 179–186.[CrossRef]
    [Google Scholar]
  22. Webster, R. G. ( 2002; ). The importance of animal influenza for human disease. Vaccine 20, S16–S20.[CrossRef]
    [Google Scholar]
  23. Zhirnov, O. P., Konakova, T. E., Wolff, T. & Klenk, H. D. ( 2002; ). NS1 protein of influenza A virus down-regulates apoptosis. J Virol 76, 1617–1625.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80991-0
Loading
/content/journal/jgv/10.1099/vir.0.80991-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error